SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (606140)8/26/2016 1:52:53 PM
From: alanrs1 Recommendation

Recommended By
skinowski

  Read Replies (1) | Respond to of 793656
 
I pondered that some and came to the conclusion that injection by needle has been around a long time in all sorts of variations. If it was a space craft, sure, or maybe they outsourced the design to some backwater close enough shop. While I generally avoid conspiracy theories, the other explanations I came up with seemed implausible.

If someone had a print, or the spec that made this a difficult engineering problem to solve, I'd love to see it, although I won't spend time looking for it myself.

Also, your use of the words 'nutty' and 'routinely' are interesting.

ARS



To: DewDiligence_on_SI who wrote (606140)8/26/2016 3:12:17 PM
From: Sdgla  Read Replies (1) | Respond to of 793656
 
I did make that consideration. Just my humble opinion. I do not see where making that delivery system approaches that of the Iron Dome project and, given that its just a needle with some ephedrine, I decided to go with the cause and effect result.

Do you have some evidence of Teva's short comings ?

If there is money to be made I am sure a competitor will attempt to breach the barrier to entry and the FDA as well.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News